Funder: Novo Nordisk
Due Dates (Anticipated): August 2026 | September 2026
Funding Amounts: Up to DKK 4,440,000 per grant (max 3 years); total call budget approx. DKK 76 million; up to DKK 1,480,000 per year.
Summary: Supports Danish clinical and translational research, with special emphasis on projects examining interactions between infectious and cardiometabolic diseases.
Key Information: Only principal investigators anchored at Danish institutions are eligible; main applicant's salary not covered.